How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement

BACKGROUND: Pediatric regulations enacted in both Europe and the USA have disrupted the pharmaceutical industry, challenging business and drug development processes, and organizational structures. Over the last decade, with science and innovation evolving, industry has moved from a reactive to a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Severin, Thomas, Corriol-Rohou, Solange, Bucci-Rechtweg, Christina, an Haack, Kristina, Fuerst-Recktenwald, Sabine, Lepola, Pirkko, Norjavaara, Ensio, Dehlinger-Kremer, Martine, Haertter, Sebastian, Cheung, S. Y. Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458895/
https://www.ncbi.nlm.nih.gov/pubmed/32030690
http://dx.doi.org/10.1007/s43441-020-00116-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458895/
https://www.ncbi.nlm.nih.gov/pubmed/32030690
http://dx.doi.org/10.1007/s43441-020-00116-4

Ejemplares similares